Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.4/5
Pegavision Corp (6491 TT)
Watchlist
7
Analysis
Health Care
•
Taiwan
Pegavision Corp is a result of a joint venture by Pegatron Corp and Kinsus Corp. The Company manufactures and sells soft contact lenses and other ophthalmic medical devices. Pegavision operates in Taiwan.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Conant Optical
•
08 Jul 2025 00:30
Shanghai Conant Optical (2276 HKG): Lens of Strong Fundamentals Makes the Growth Optics Visible
Shanghai Conant Optical to invest in research and development of smart glasses and XR headsets with proceeds from recent placement. The company...
Tina Banerjee
Follow
257 Views
Share
bullish
•
Quantitative Analysis
•
08 Jun 2025 23:10
TWSE Short Interest Weekly (Jun 6th): Cathay Financial, Ctbc Financial, Fubon Financial
We analyzed TWSE short interest report for the past week and highlighted short interest changes in Cathay Financial (2882 TT), Ctbc Financial (2891...
Ke Yan, CFA, FRM
Follow
312 Views
Share
bearish
•
Quantitative Analysis
•
09 Mar 2024 02:56
TWSE Short Interest Weekly (Mar 8th): TSMC, ASE, Mediatek, Yageo, Faraday Tech, Chung-Hsin, Momo.Com
We analyzed TWSE short interest report for the past week and highlighted short interest changes in TSMC, ASE, Mediatek, Yageo, Faraday Tech, Chung...
Ke Yan, CFA, FRM
Follow
788 Views
Share
bearish
•
Pegavision Corp
•
05 Apr 2023 15:24
Pegavision Corp (6491 TT): Near-Term Concerns To Limit Upside Potential
During 1Q23, Pegavision recorded revenue of NT$1.5B, down 2% YoY and 18% QoQ. With China and Japan reopening the demand should have been strong....
Tina Banerjee
Follow
527 Views
Share
bullish
•
PDD Holdings
•
06 Feb 2023 21:36
EM Outperformance to Continue (Vs. EAFE) -- Add on a Pullback; DXY Needs to Hold Below $106
EM vs. EAFE ratio (local currency) shows EM has outperformed relative to EAFE since the $DXY peaked in November 2022. If the DXY remains below...
Vermilion Research
Follow
431 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x